Regulatory · WADAresearch use only
WRegulatory · WADA
WADA prohibited list status
WADA prohibits many peptides in this library. The prohibition falls under four sections.
S0Non-approved substances
S2Peptide hormones and growth factors
S2.2Growth hormone fragments and analogs
S2.2.4GHRH analogs and GH secretagogues
Eleven compounds carry no WADA name: Semaglutide, Tirzepatide, Thymosin Alpha-1, Epithalon, Pinealon, GHK-Cu, Humanin, DSIP, KPV, FOXO4-DRI, Melanotan I.
Two compounds sit outside both groups. WADA does not name Dihexa directly, and the catch-all language in section S2 covers growth-factor modulators. Elamipretide changed status when the FDA approved it in September 2025.
One instruction. Check the live WADA list before any decision that involves competition. The list changes each year. This page reports the 2025 and 2026 editions cited in our profiles.
Open the WADA Prohibited List →